Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria

Detalles Bibliográficos
Autores principales: Di Loreto, Chiara, Minarelli, Viviana, Nasini, Giovanni, Norgiolini, Roberto, Del Sindaco, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174395/
https://www.ncbi.nlm.nih.gov/pubmed/35461397
http://dx.doi.org/10.1007/s13300-022-01263-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174395/
https://www.ncbi.nlm.nih.gov/pubmed/35461397
http://dx.doi.org/10.1007/s13300-022-01263-7

Ejemplares similares